HIST1H2BJ | Histone cluster 1, H2bj | | | | | | Tissue enhanced |
HIST1H3A | Histone cluster 1, H3a | | | | | | Tissue enhanced |
HOOK1 | Hook microtubule-tethering protein 1 | | | | | | Tissue enhanced |
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
HYLS1 | Hydrolethalus syndrome 1 | Disease related genes
| | | | | Tissue enhanced |
IL4I1 | Interleukin 4 induced 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
INHA | Inhibin, alpha | Predicted secreted proteins
| | | | | Tissue enhanced |
KIAA1683 | KIAA1683 | | | | | | Tissue enhanced |
KIF18A | Kinesin family member 18A | | | | | | Tissue enhanced |
KIF2C | Kinesin family member 2C | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
KLHDC9 | Kelch domain containing 9 | | | | | | Tissue enhanced |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
LHCGR | Luteinizing hormone/choriogonadotropin receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRRC36 | Leucine rich repeat containing 36 | | | | | | Tissue enhanced |
LRRC56 | Leucine rich repeat containing 56 | | | | | | Tissue enhanced |
LRRC6 | Leucine rich repeat containing 6 | Disease related genes
| | | | | Tissue enhanced |
MTFR2 | Mitochondrial fission regulator 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MYO16 | Myosin XVI | | | | | | Tissue enhanced |
NANOG | Nanog homeobox | Transcription factors
| | | | | Tissue enhanced |
NCAPH | Non-SMC condensin I complex, subunit H | | | | | | Tissue enhanced |
NEK5 | NIMA-related kinase 5 | Enzymes
| | | | | Tissue enhanced |
NPTX2 | Neuronal pentraxin II | Predicted secreted proteins
| | | | | Tissue enhanced |
NSUN7 | NOP2/Sun domain family, member 7 | | | | | | Tissue enhanced |
OR7C1 | Olfactory receptor, family 7, subfamily C, member 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OSBP2 | Oxysterol binding protein 2 | | | | | | Tissue enhanced |
PBK | PDZ binding kinase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
PCDHB2 | Protocadherin beta 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PIK3R3 | Phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | Cancer-related genes RAS pathway related proteins
| | | | | Tissue enhanced |
PRPH | Peripherin | | | | | | Tissue enhanced |
PRTG | Protogenin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RAB11FIP5 | RAB11 family interacting protein 5 (class I) | Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
RAD51 | RAD51 recombinase | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
RASGEF1C | RasGEF domain family, member 1C | | | | | | Tissue enhanced |
RFX3 | Regulatory factor X, 3 (influences HLA class II expression) | Transcription factors
| | | | | Tissue enhanced |
RIMS4 | Regulating synaptic membrane exocytosis 4 | | | | | | Tissue enhanced |
RP5-1052I5.2 | Heparan sulfate 2-O-sulfotransferase 1 | | | | | | Tissue enhanced |
SALL4 | Spalt-like transcription factor 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
SCRG1 | Stimulator of chondrogenesis 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
SDK2 | Sidekick cell adhesion molecule 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
SEL1L2 | Sel-1 suppressor of lin-12-like 2 (C. elegans) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SPAG17 | Sperm associated antigen 17 | | | | | | Tissue enhanced |
SPATA6L | Spermatogenesis associated 6-like | | | | | | Tissue enhanced |
STAG3 | Stromal antigen 3 | | | | | | Tissue enhanced |
TIGD4 | Tigger transposable element derived 4 | | | | | | Tissue enhanced |
TMEM229A | Transmembrane protein 229A | Predicted membrane proteins
| | | | | Tissue enhanced |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
TSPAN19 | Tetraspanin 19 | Predicted membrane proteins
| | | | | Tissue enhanced |
TSPYL5 | TSPY-like 5 | | | | | | Tissue enhanced |
TTC39A | Tetratricopeptide repeat domain 39A | Predicted membrane proteins
| | | | | Tissue enhanced |